Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Urology|March 26, 2002
Selective activation of members of the signal transducers and activators of transcription family in prostate carcinomaZuyao Ni, Wei Lou, Soo Ok Lee, et al.
Oncogene|April 30, 2004
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasisTong-Xin Xie, Daoyan Wei, Mingguang Liu, et al.
The Prostate|October 6, 2012
Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complexZhijian Duan, June X Zou, Ping Yang, et al.
The Prostate|April 26, 2006
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA)Soo Ok Lee, Jae Yeon Chun, Nagalakshmi Nadiminty, et al.
The Prostate|July 12, 2002
Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude miceFernando DeMiguel, Soo Ok Lee, Wei Lou, et al.
The Prostate|June 18, 2011
RhoGDIα suppresses growth and survival of prostate cancer cellsYezi Zhu, Ramakumar Tummala, Chengfei Liu, et al.
Biomedicines|October 20, 2020
The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on TherapyElisabeth A Messner, Thomas M Steele, Maria Malvina Tsamouri, et al.
American Journal of Clinical and Experimental Urology|September 13, 2019
Wntless promotes cellular viability and resistance to enzalutamide in castration-resistant prostate cancer cellsAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
Cancer|April 22, 2020
Germline and somatic DNA repair gene alterations in prostate cancerMarc A Dall'Era, John D McPherson, Allen C Gao, et al.
Molecular Cancer Therapeutics|July 30, 2021
Activation of the <i>ABCB1</i> Amplicon in Docetaxel- and Cabazitaxel-Resistant Prostate Cancer CellsAlan P Lombard, Wei Lou, Cameron M Armstrong, et al.
Pageof 15